FDA Drug Shortage Database
Dexamethasone (Decadron) shortage
The FDA Drug Shortage Database lists 2 of 19 dexamethasone presentations as limited or unavailable (updated October 6, 2026); the first entry was posted on February 8, 2019. 17 more presentations are on the list as available.
- Generic listed
- In shortage
Check it at the source: the FDA Drug Shortage Database.
Which strengths are short?
| Strength | Limited or unavailable now | Listed now, available | Resolved or discontinued |
|---|---|---|---|
| 4mg/1ml injection | 0 | 10 | 0 |
| 10mg/1ml injection | 2 | 7 | 0 |
Which presentations are listed?
Limited or unavailable now (2)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-0212-10) | Fresenius Kabi USA, LLC | Current posted February 8, 2019, updated September 15, 2026 | Limited Availability; Demand increase for the drug |
| Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-212-10) | Fresenius Kabi USA, LLC | Current posted February 8, 2019, updated September 15, 2026 | Limited Availability; Demand increase for the drug |
Listed now, available (17)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 63323-506-01) | Fresenius Kabi USA, LLC | Current posted February 8, 2019, updated October 6, 2026 | Available |
| Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 70069-021-25) | Somerset Therapeutics, LLC | Current posted February 8, 2019, updated September 11, 2026 | Available |
| Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 0641-0367-25) | Hikma Pharmaceuticals USA, Inc. | Current posted February 8, 2019, updated September 18, 2026 | Available |
| Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 55150-304-25) | Eugia US LLC | Current posted February 8, 2019, updated October 2, 2026 | Available |
| Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 63323-516-10) | Fresenius Kabi USA, LLC | Current posted February 8, 2019, updated October 6, 2026 | Available |
| Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 67457-420-10) | Mylan Institutional, a Viatris Company | Current posted February 8, 2019, updated October 5, 2026 | Available |
| Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 70069-025-10) | Somerset Therapeutics, LLC | Current posted February 8, 2019, updated September 11, 2026 | Available |
| Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6145-25) | Hikma Pharmaceuticals USA, Inc. | Current posted February 8, 2019, updated September 18, 2026 | Available |
| Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6146-25) | Hikma Pharmaceuticals USA, Inc. | Current posted February 8, 2019, updated September 18, 2026 | Available |
| Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-01) | Fresenius Kabi USA, LLC | Current posted February 8, 2019, updated October 6, 2026 | Available |
| Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-05) | Fresenius Kabi USA, LLC | Current posted February 8, 2019, updated October 6, 2026 | Available |
| Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-30) | Fresenius Kabi USA, LLC | Current posted February 8, 2019, updated October 6, 2026 | Available |
| Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-421-30) | Mylan Institutional, a Viatris Company | Current posted February 8, 2019, updated October 5, 2026 | Available |
| Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-422-54) | Mylan Institutional, a Viatris Company | Current posted February 8, 2019, updated October 5, 2026 | Available |
| Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-423-12) | Mylan Institutional, a Viatris Company | Current posted February 8, 2019, updated October 5, 2026 | Available |
| Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-0210-10) | Fresenius Kabi USA, LLC | Current posted February 8, 2019, updated October 6, 2026 | Available |
| Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-210-10) | Fresenius Kabi USA, LLC | Current posted February 8, 2019, updated October 6, 2026 | Available |
Source: FDA Drug Shortage Database via openFDA, read October 8, 2026
Are medicines for the same conditions short too?
Medicines whose labels share an indication with this one, and their own shortage status; listed as records, not substitutes.
| Medicine | Shared indication | Shortage | Generic labelers | Pharmacy cost |
|---|---|---|---|---|
| Prednisone | Osteoarthritis, Asthma, Allergies, Crohn's disease and ulcerative colitis, Herpes and shingles, Eczema (atopic dermatitis), Leukemia, lymphoma and myeloma, Anemia | No current entry | 45 labelers | $0.0643 per tablet 20 mg tablet |
| Hydrocortisone | Osteoarthritis, Asthma, Allergies, Crohn's disease and ulcerative colitis, Herpes and shingles, Leukemia, lymphoma and myeloma | A presentation being discontinued | 49 labelers | $0.0613 per gram 1% cream |
| Methylprednisolone | Osteoarthritis, Allergies, Crohn's disease and ulcerative colitis, Herpes and shingles, Leukemia, lymphoma and myeloma, Anemia | In shortage | 35 labelers | $0.121 per tablet 4 mg tablet |
| Prednisolone | Osteoarthritis, Asthma, Allergies, Crohn's disease and ulcerative colitis, Herpes and shingles, Eczema (atopic dermatitis), Leukemia, lymphoma and myeloma, Anemia | No current entry | 25 labelers | $4.72 per mL 1% eye drop |
| Budesonide | Asthma, Crohn's disease and ulcerative colitis | No current entry | 30 labelers | $0.498 per capsule 3 mg capsule |
| Cortisone | Osteoarthritis, Asthma, Allergies, Crohn's disease and ulcerative colitis, Herpes and shingles, Leukemia, lymphoma and myeloma | No current entry | 1 labeler | n/a |
| Montelukast | Asthma, Allergies | A presentation being discontinued | 36 labelers | $0.0419 per tablet 10 mg tablet |
| Theophylline | Asthma | No current entry | 26 labelers | $0.330 per tablet 300 mg tablet |
| Albuterol | Asthma | Resolved | 40 labelers | $0.288 per tablet 2 mg tablet |
| Zafirlukast | Asthma | No current entry | 5 labelers | $0.623 per tablet 20 mg tablet |
| Zileuton | Asthma | No current entry | 5 labelers | $2.05 per tablet 600 mg tablet |
| Ephedrine | Asthma | No current entry | 19 labelers | n/a |
Source: FDA drug labels, FDA Drug Shortage Database, NDC Directory, CMS NADAC of October 7, 2026 (FDA files October 8, 2026)
What next?
- Every shortage now
- medicines by presentations in shortage